Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study
Ruzena Tkacova (Kosice, Slovakia), Ruzena Tkacova, Jan Svancara, Vladimir Koblizek, Attila Somfay, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Jurij Sorli, Alvils Krams, Zuzana Zbozinkova, Marc Miravitlles, Arschang Valipour
Source: International Congress 2016 – In-patient and out-patient COPD management
Session: In-patient and out-patient COPD management
Session type: Poster Discussion
Number: 556
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ruzena Tkacova (Kosice, Slovakia), Ruzena Tkacova, Jan Svancara, Vladimir Koblizek, Attila Somfay, Branislava Milenkovic, Adam Barczyk, Kirill Zykov, Neven Tudoric, Kosta Kostov, Jurij Sorli, Alvils Krams, Zuzana Zbozinkova, Marc Miravitlles, Arschang Valipour. Pharmacotherapy of COPD in Central and Eastern Europe - The POPE study. Eur Respir J 2016; 48: Suppl. 60, 556
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Epidemiology of COPD in North America and Europe: Results from a systematic literature review Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study Source: Eur Respir J, 49 (5) 1601446; 10.1183/13993003.01446-2016 Year: 2017
LATE-BREAKING ABSTRACT: Phenotypes of COPD in central and Eastern Europe - The POPE study Source: International Congress 2015 – COPD: interesting notes Year: 2015
Ethnicity and COPD in South London - is there less COPD in the black population? Source: International Congress 2014 – Management of COPD in primary care Year: 2014
GOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) Cohort Source: Eur Respir J , 49 (4) 1602518; DOI: 10.1183/13993003.02518-2016 Year: 2017
Respiratory symptoms, bronchitis and asthma in children of Central and Eastern Europe Source: Eur Respir J 2002; 20: 890-898 Year: 2002
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey Source: Eur Respir J 2002; 20: 799-805 Year: 2002
Evaluation of respiratory symptoms in COPD patients from seven Latin America countries: The LASSYC Study Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017
Geographical variation of prevalence, and under-diagnosis of COPD in urban and rural communities of China: Finding from China Kadoorie Biobank of 0.5M people Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population Year: 2013
LATE-BREAKING ABSTRACT: The use of benzodiazepines in COPD: A population-based study of Norway Source: Annual Congress 2013 –Highlights in epidemiology of respiratory disease Year: 2013
The confronting COPD survey in Central and Eastern Europe Source: Eur Respir J 2005; 26: Suppl. 49, 296s Year: 2005
Gender differences in long-term outcomes of COPD: A population based study in Italy Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014
COPD prevalence in Argentina: The EPOC.AR study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
Prevalence of chronic bronchitis in the Middle-East and North Africa: Interim results of the BREATHE study Source: Annual Congress 2011 - Respiratory epidemiology: prevalence, incidence and remission Year: 2011
The prevalence of COPD in Annaba, Algeria: Results of the BOLD study Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014
The disease burden of mild asthmatics in China Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important? Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015
Mortality after COPD-exacerbations: Learning from epidemiology Source: International Congress 2014 – Clinical presentations Year: 2014
The Italian registry for severe/uncontrolled asthma Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016